Laparoscopic Management of Bowel Endometriosis: Predictors of Severe Disease and Recurrence

Camran Nezhat, Babak Hajhosseini, Louise P King
JSLS : Journal of the Society of Laparoendoscopic Surgeons · 2011 · vol. 15(4) , pp. 431–438 · doi:10.4293/108680811x13176785203752 · PMID:22643495 · PMC3340949 · W2057485580
article OA: gold CC0 ⤵ 47 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This retrospective study identified prior surgery and abnormal uterine bleeding as predictors of severe bowel endometriosis, and higher BMI as a predictor of recurrence, with 87% of patients experiencing symptom improvement post-laparoscopy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text ⓘ

This retrospective chart review studied 193 women with pathologically confirmed bowel endometriosis who underwent laparoscopic surgery at a tertiary referral center (2002–2009), abstracting preoperative symptoms, operative findings, staging (1996 ASRM), perioperative morbidity, pain outcomes, and recurrence over 1–8 years. Most patients had stage IV disease (61%) with frequent multifocal intestinal involvement and concomitant extraintestinal lesions, and laparoscopic management was associated with no major complications and 87% achieving symptom amelioration by the first postoperative month, while 10% required a second laparoscopic intervention for recurrent endometriosis. Higher-stage disease was associated with presenting abnormal uterine bleeding and a history of prior laparoscopic surgery, whereas recurrence in the small recurrence subanalysis was significantly higher with BMI (P=.002) but not clearly linked to age, symptoms, prior surgery, stage, or conventional versus robot-assisted laparoscopy. The study’s main caveat is that it was based on retrospective single-center chart data with limited power for recurrence predictors (only 19 recurrent cases). This paper is centrally about endometriosis — it analyzes predictors of severe (stage IV) bowel disease and recurrence following laparoscopic treatment, including performance of bowel resections and associated recurrence patterns.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND AND OBJECTIVES: The identification of highstage and recurrent cases of bowel endometriosis is critical, because these cases require careful surgical planning. We aim to describe the clinical characteristics of women with bowel endometriosis, our principles in laparoscopic management of this pathology, and to identify predictors of severe disease and recurrence. METHODS: This was a retrospective study of 193 patients with pathologically confirmed bowel endometriosis. RESULTS: Predictors of higher-stage endometriosis include a history of previous laparoscopic surgery (P=.04) and a presenting complaint of abnormal uterine bleeding (P=.01). The higher the stage of endometriosis, the more likely there would be coexistent urinary tract endometriosis (P=.02), a need for enterolysis (P=.002), ovarian cystectomy (P<.001), and bowel resection (P=.01) performed during laparoscopy. Patients with higher body mass index (BMI) had significantly higher recurrence rates of endometriosis compared to those with lower BMI (P=.002). Within our cohort, 87% of our patients achieved amelioration of symptoms by the end of the first postoperative month. CONCLUSIONS: Our study confirms that laparoscopic management of bowel endometriosis is safe and effective. We found 2 statistically significant predictors of higher-stage disease that should prompt careful surgical planning. Obesity is associated with a higher rate of recurrence of endometriosis.
Full text 19,650 characters · extracted from pmc-nxml · 5 sections · click to expand

Results

During the 7 and ½ year study period, 193 patients with pathologically confirmed bowel endometriosis were identified. The mean age of the study group was 36±7 years (range, 17 to 52) with a mean BMI of 23.2±3.1kg/m 2 (range, 18.2 to 34.3). The most common preoperative presenting symptom was chronic pelvic pain. At the time of presentation, 59% of patients had GI symptoms, but only 36% (n=70) included it as one of their chief complaints. Of those with GI symptoms, constipation and dyschezia were the most common. Urinary frequency was the most common urinary complaint at the time of presentation. A complete list of presenting symptoms can be found in Table 1 along with baseline characteristics. A total of 45% of patients described their symptoms as cyclic in nature, occurring at or around the time of menstruation. A total of 44% (n=85) had a history of laparoscopic surgery at other medical centers; these were mainly for treatment of endometriosis. Of patients, 11% (n=22) had a history of depression, and 6% (n=11) had some type of uterine anomaly (bicornuate or septate uterus). Baseline Characteristics Total >100% because most patients presented with more than 1 symptom. Stage IV endometriosis was present in 61% (n=117) of patients ( Table 1 ) . More than half of the patients (58%) had multiple sites of intestinal endometriosis, with the recto-sigmoid colon, recto-vaginal septum, and appendix being the most common sites in descending order of frequency. A total of 97% (n=187) of patients also had endometriotic lesions at sites other than the intestinal tract, with ovaries being the most common nongastrointestinal site of endometriosis lesions. Coexistence of urinary tract (bladder and/or ureter) endometriosis was seen in 62% (n=119) of patients and was treated at the time of surgery. The complete list of sites of endometriosis is provided in Table 2 . During surgery, 11% (n=22) of patients were concomitantly diagnosed with adenomyosis. Sites of Endometriosis (n=193) Total >100% because most patients had more than 1 site of endometriosis. Disc excision, segmental bowel resection, and appendectomy were performed on 73% (n=141), 1.6% (n=3), and 37% (n=72) of patients, respectively. Of 72 appendectomies, pathology reports indicated an abnormal appendix (endometriosis/fibrotic obliteration) in 65% of cases. Varying degrees of enterolysis were required in 65% (n=126) of patients. One patient underwent a combination of laparoscopy for treatment of abdominopelvic endometriosis and thoracoscopy for treatment of thoracic endometriosis. The operative procedures performed on patients in the study are listed in Table 3 . All procedures were carried out successfully by laparoscopy without conversion to laparotomy. We used a combination of conventional and robot-assisted laparoscopy in 7 cases (4%). Laparoscopic Procedures Performed (n=193) Total >100% because all patients had more than 1 procedure performed. No major complications occurred. These were defined as rectovaginal fistula, anastomotic leakage/stenosis, inadvertent ureteral damage, accidental bowel perforation, and pelvic abscesses. Minor complications occurred in 7% (n=13) of patients and included 4 cases of transient urinary retention and 9 cases of incision-site infection. All of these minor complications were treated in an outpatient setting. Short-term follow-up visits in the outpatient setting were routinely conducted 1, 3, and 6 months postoperatively. Overall, 87% (n=167) of the entire study group achieved amelioration of symptoms by the end of the first postoperative month. Long-term follow-ups were conducted by either office visits or phone calls on a yearly basis. During 1 to 8 years of long-term follow-up (mean, 4.5 years), 10% (n=19) had recurrence of endometriosis that necessitated a second laparoscopic intervention. Similarly to their initial laparoscopic evaluation, the majority of patients with recurrent cases were diagnosed with multiple sites of endometriosis at the time of the second surgery. The 3 most common sites of recurrent endometriosis in decreasing order of frequency were genital tract (8%), urinary tract (6%), and GI tract (4%). We divided our cohort into 2 groups for further analysis: 1 group with lower-stage endometriosis (stages I, II, & III) and 1 group with high-stage endometriosis (stage IV). There were 2 preoperative factors significantly related to higher stage disease: a presenting complaint of abnormal uterine bleeding (P=.01) or a history of laparoscopic surgery (P=.04). There was also a significant association between the stage of endometriosis and some of the operative procedures performed. Patients with stage IV endometriosis were more likely to need enterolysis (P=.002), ovarian cystectomy (P<.001), and segmental bowel resection/disc excision (P=.01) performed during their surgeries, as compared with those with less advanced stages of disease. Coexistent urinary tract endometriosis was significantly more likely in patients with more advanced stages of endometriosis (P=.02). A complete list of variables and their associations with stage of endometriosis is shown in Table 4 . No significant associations were noted between the stage of endometriosis and the patients’ BMI, type of surgery (conventional vs. robot-assisted laparoscopy), or frequency of postoperative complications. Variables Associated with Stage of Endometriosis We conducted a subanalysis of 19 patients with recurrent endometriosis to identify possible predictors of recurrent disease. Patients with higher BMI had significantly higher recurrence rate of endometriosis compared to those with lower BMI (P=.002). No significant correlations existed between recurrence rate and age, presenting symptoms, or history of previous laparoscopic surgery. Although a higher recurrence rate was seen in patients with stage IV endometriosis compared to patients with less advanced stages, the relationship did not reach statistical significance. There was no significant difference between recurrence rate and the type of surgery performed (conventional vs. robot-assisted laparoscopy).

Discussion

Bowel endometriosis was first described in 1922 by Sampson. 14 It affects between 3% and 37% of patients with a diagnosis of endometriosis. It can present at any level from the anal canal to the small intestine; however, the most frequent locations of involvement are the rectum and sigmoid colon. 3 , 4 , 15 , 16 Intestinal implantation begins on the serosa and sometimes invades the muscularis propria but rarely affects the mucosa. 4 , 8 , 17 Patients with endometriosis present with different clinical complaints at various stages of disease. 5 The majority of those with bowel involvement develop a variety of GI complaints including constipation, diarrhea, abdominal bloating, tenesmus, lower abdominal pain, and occasionally rectal bleeding. 3 , 5 , 8 Symptoms usually occur cyclically at or about the time of menstruation. 5 Appendiceal endometriosis can mimic acute appendicitis, or it may contribute to chronic pelvic pain. 18 – 23 Bowel obstruction is a rare complication that can be confused with carcinoma 3 , 17 , 24 The differential diagnosis of bowel endometriosis includes irritable bowel syndrome, inflammatory bowel disease, diverticulitis, and bowel carcinoma. 8 , 17 , 25 Several techniques have been proposed to aid in the diagnosis of bowel endometriosis. These include barium enema, transvaginal ultrasound, transrectal ultrasound, colonoscopy, computed tomography, and magnetic resonance imaging. 8 Although studies have shown varying levels of success using these methodologies, 23 , 26 – 28 it is generally believed that they are of little diagnostic value. 3 , 7 , 29 , 30 In short, no clear guidelines exist for the evaluation of patients with suspected bowel endometriosis. When clinical evidence suggests the presence of deeply infiltrating endometriosis, we use imaging studies to map the extent of disease. Nevertheless, laparoscopic assessment in combination with histological examination of excised lesions remains the gold standard for diagnosis of any type of endometriosis including that of the bowel. 4 – 5 , 30 Historically, 2 major approaches exist for management of bowel endometriosis: medical and surgical. Medical treatments are focused on hormonal manipulation of the menstrual cycle in an attempt to produce a pseudo-pregnancy, pseudo-menopause, or chronic anovulation. 6 Alternatively, targeting aromatase, cyclooxygenase-2, estrogen receptor β, or progesterone receptors may reduce pelvic pain and decrease visible endometriotic tissue. 31 – 33 Although hormonal modulation may be useful in some settings like preoperative preparation, 23 , 34– 35 it rarely yields satisfactory long-term results. 5 , 8 , 36 , 37 This may be because of fibrotic changes and scar tissue, resulting in pelvic pain that is refractory to medical therapy. 3 Currently, surgical removal of endometriotic lesions appears to be the most effective treatment, because it is associated with a significant improvement in pain, quality of life, and fertility status. 8 , 38 , 39 Successful laparoscopic bowel resection for the treatment of bowel endometriosis was first described in 1988. 10 , 40 , 41 Over the last 2 decades, a variety of laparoscopic techniques have proven effective in the treatment of intestinal endometriosis. These include laser vaporization, shaving, disc excision, segmental bowel resection, and appendectomy, all of which can be performed successfully via laparoscopy. 11 , 12 Advances in laparoscopic management of severe bowel endometriosis would not have been possible without multiple advances in instrumentation and the introduction of videolaparoscopy. 42 – 45 Before the introduction of videolaparoscopy, the utility of operative laparoscopy was diminished by two major drawbacks: poor visualization into the intra-abdominal cavity with one eye and the inability of the operative team to view the operative field. Both of these limitations were rectified with the incorporation of the videolaparoscope. 43 , 44 These advances made it possible to treat even the most extensive pathology laparoscopically. Several authors agree that laparoscopic bowel resection is feasible and can be performed safely when needed. 46 – 49 However, a debate exists regarding the extent of intestinal wall resection necessary to adequately treat the disease. 36 Segmental bowel resection represents the most radical approach but is characterized by a specific pattern of major postoperative complications and lower pregnancy rates compared with less aggressive methods, such as disc excision. 11 , 12 , 50 Those in favor of segmental resection argue that the wide margin of excision achieved results in a lower recurrence rate of the endometriosis. 37 , 51 – 53 However, the dissection necessary to achieve mobilization for a segmental bowel resection poses a greater risk of inadvertent trauma to the superior and especially inferior hypogastric plexus. Injury to these plexus could cause persistent bowel and urinary symptoms postoperatively. The majority of our patients were managed without segmental bowel resection. They achieved high levels of pain relief and excellent long-term outcome with low recurrence rates and no major complications. Because colorectal endometriosis is considered a benign disease, 22 we feel that segmental bowel resection should remain the last resort, appropriate only for those with lesions involving more than one-third of the circumference of the bowel or those with partial bowel obstruction. In addition, intraoperative proctosigmoidoscopy should be performed when necessary. This procedure has been shown to be effective in assessment of bowel wall invasion, detecting bowel injuries during laparoscopy and evaluating anastomosis. 54 Similarly to other studies, 55 we found that concomitant genital and urinary tract endometriosis are frequently seen in patients with bowel endometriosis. Therefore, a careful and systematic inspection of the pelvic and abdominal cavity is necessary to detect and treat all possible lesions. Moreover, in findings that echo those of Redwine and Chapron et al, 56 , 57 we found that a large portion of our patients had multifocal endometriosis lesions of the intestines; however, in contrast to their opinions, we believe that even multifocal cases of bowel endometriosis can be managed successfully by laparoscopy with no need for conversion to laparotomy. We found that obese or overweight women had a significantly higher rate of recurrence compared with patients with normal BMI. It is unlikely that the higher recurrence rate in this subgroup is due to incomplete treatment of endometriosis, as it has been demonstrated that laparoscopic approach in treatment of endometriosis is not significantly influenced by BMI in terms of surgical outcome or complications rate. 58 Instead, this could be partly due to the fact that obese women have more adipose tissue and consequently higher output of estrogen produced by the aromatase activity in those tissues. This would be consistent with the estrogen-dependent nature of the disease. However, we did not find any significant association between BMI and disease stage. Although not clinically specific, we demonstrated 2 statistically significant preoperative predictors of severe disease: a presenting complaint of abnormal uterine bleeding, a history of gynecologic laparoscopy, or both of these. Our study has several limitations. Our center is a tertiary referral center for endometriosis; therefore, our patients may not be representative of the population as a whole. The retrospective nature of this study limited our ability to control for confounding factors and thus limited our ability to reliably predict those factors that lead to recurrence. All the presenting symptoms in our study were self-reported. Our study was limited to patients with proven bowel endometriosis, so we were not able to determine how valuable GI symptoms may be in predicting the presence of bowel endometriosis. To determine the predictive nature of gastrointestinal symptoms and adequately compare disc excision to segmental bowel resection for treatment of bowel endometriosis, further prospective controlled trials are warranted. We also believe that, based on our findings in terms of relation between higher BMI and higher rate of recurrence, future studies are required to investigate the association between preoperative estrogen levels and recurrence of endometriosis.

Conclusions

Intestinal endometriosis should be suspected in women of childbearing age who present with gastrointestinal symptoms and a history of endometriosis. High-stage and recurrent cases necessitate careful surgical planning. Our study confirms that laparoscopic management of bowel endometriosis is feasible, safe, and efficient. All patients who undergo laparoscopy for treatment of endometriosis or chronic pelvic pain should be counseled regarding the possibility of bowel involvement and the risk, benefits, and alternatives of treatment. Although it may be technically demanding, removal of endometriotic lesions is critical for symptomatic relief and if carried out in specialist centers by surgeons with proper training and experience, leads to positive results with minimal morbidity.

Introduction

Endometriosis is an estrogen-dependent inflammatory disease 1 that was first described in 1860. 2 It is a progressive disease that affects 10% to 15% of reproductive age women and nearly half of all infertile women. It is defined as the presence of endometrial-like tissue outside of the uterine cavity. 3 , 4 The condition is commonly associated with chronic pelvic pain and infertility. 5 , 6 Superficial or deep endometriosis can involve virtually any pelvic or extrapelvic organ. 7 The most common site of extragenital endometriosis is the intestinal tract, which accounts for approximately 80% of all extragenital endometriosis. 3 , 4 Although bowel endometriosis may cause severe gastrointestinal (GI) symptoms, these disturbances are frequently not adequately investigated at the time of gynecologic evaluation. As a result, bowel endometriosis may be an unexpected finding at surgery, and the lesions may not be treated due to the lack of preoperative informed consent or surgical inexperience. 8 Moreover, the extent of intestinal wall resection necessary to adequately treat the disease is highly debated. Identifying high-stage and recurrent cases is critical, because they require careful surgical planning. This article will describe the clinical characteristics of women with bowel endometriosis and will present the results of our own experience in laparoscopic management of the disease. We will identify possible predicting factors for the extent of the disease and its recurrence. It is useful for gynecologists and general surgeons to understand the spectrum of intestinal tract endometriosis so as to be able to anticipate its presence and plan accordingly.

Materials|Methods

We reviewed the charts of all patients at our tertiary referral center who underwent laparoscopic surgery between February 2002 and September 2009 and identified all those with pathologically confirmed bowel endometriosis. The final cohort consisted of 193 patients. We also reviewed the operative reports to confirm that a diagnosis of bowel endometriosis was made during the surgery and that endometriotic lesions were found to infiltrate beyond the serosal layer of the intestinal wall. We then abstracted data from the charts of all 193 patients with respect to age, body mass index (BMI), previous surgery, presenting symptoms and their timing, intraoperative findings and procedures, sites and stage of endometriosis, short- and long-term follow-up and pain relief, perioperative morbidity, and recurrence of endometriosis. The disease was staged according to the 1996 American Society for Reproductive Medicine classification, based on the operative findings. 9 Before surgery, each patient underwent a routine gynecologic and rectovaginal examination and a transvaginal ultrasound. Each patient also underwent mechanical bowel preparation and received perioperative intravenous antibiotics. The lesion distribution, depth of invasion, and level of stricture dictated the laparoscopic method of treatment of intestinal endometriosis. Superficial lesions that did not invade the muscularis were shaved with CO 2 laser. Disc excision was performed when endometriotic lesions partially invaded the muscular layer, but not the mucosa of the bowel. 10 – 12 When infiltrative lesions involved more than one-third of the circumference of the bowel or caused partial bowel obstruction, a segmental resection with end-to-end anastomosis was performed. We removed all visible endometriotic foci in other parts of the pelvis, abdomen, and thoracic cavity as needed. 13 Preoperative and intraoperative consultation with a colorectal surgeon, urologist, or thoracic surgeon was obtained as appropriate. Descriptive statistics were calculated and tabulated. Normally distributed data are presented as mean ± standard deviation (SD). Associations between study outcomes and potential predictors were explored using the independent sample t test for continuous variables and the chi-square test for categorical variables. A P value <.05 was considered to be statistically significant. All analyses were conducted using SPSS statistical software version 15 (SPSS Inc., Chicago, IL). The Institutional Review Boards of the Stanford University Medical Center and El Camino Hospital approved this study.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisbowel_endometriosis

MeSH descriptors

Endometriosis Intestinal Diseases Laparoscopy Adolescent Adult Chi-Square Distribution Endometriosis Female Humans Intestinal Diseases Laparoscopy Middle Aged Obesity Obesity Recurrence Retrospective Studies Risk Factors Severity of Illness Index Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (63)

Cited by (47)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:11.197438+00:00
License: CC0 · commercial use OK